Showing results (31-40 of 109) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|October 29, 2021
JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesotheliomaYosuke Miyamoto, Toshiyuki Kozuki, Keisuke Aoe, et al.
International Journal of Oncology|June 15, 2006
Elevated pleural fluid RCAS1 is a diagnostic marker and outcome predictor in lung cancer patientsKeisuke Aoe, Akio Hiraki, Koichi Yamazaki, et al.
BMC Cancer|April 27, 2019
Physician requests by patients with malignant pleural mesothelioma in JapanYasuko Nagamatsu, Isao Oze, Keisuke Aoe, et al.
Internal Medicine (Tokyo, Japan)|December 17, 2016
Survival from an Acute Exacerbation of Idiopathic Pulmonary Fibrosis with or without Direct Hemoperfusion with a Polymyxin B-immobilized Fiber Column: A Retrospective AnalysisKeiji Oishi, Keisuke Aoe, Yusuke Mimura, et al.
Internal Medicine (Tokyo, Japan)|September 15, 2005
Serum hemoglobin level determined at the first presentation is a poor prognostic indicator in patients with lung cancerKeisuke Aoe, Akio Hiraki, Tadashi Maeda, et al.
Oncology Reports|November 7, 2012
CD9 expression as a favorable prognostic marker for patients with malignant mesotheliomaVishwa Jeet Amatya, Yukio Takeshima, Keisuke Aoe, et al.
Scientific Reports|July 10, 2024
Characterizing soluble immune checkpoint molecules and TGF-β<sub>1,2,3</sub> in pleural effusion of malignant pleural mesotheliomaRiki Okita, Tomoya Senoo, Yuka Mimura-Kimura, et al.
Blood Purification|September 7, 2020
Cytokine Adsorption to Polymyxin B-Immobilized Fiber: An in vitro StudyToshiaki Utsunomiya, Yuka Mimura-Kimura, Takeshi Yamamoto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 22, 2002
Synergistic effects of topoisomerase I inhibitor, 7-ethyl-10-hydroxycamptothecin, and irradiation in a cisplatin-resistant human small cell lung cancer cell lineHiroyuki Kohara, Masahiro Tabata, Katsuyuki Kiura, et al.
Cancer Science|January 28, 2021
Capmatinib in Japanese patients with MET exon 14 skipping-mutated or MET-amplified advanced NSCLC: GEOMETRY mono-1 studyTakashi Seto, Kadoaki Ohashi, Shunichi Sugawara, et al.
Pageof 11